Complement in Metastasis: A Comp in the Camp

por Ajona, Daniel, Ortiz-Espinosa, Sergio, Pio, Ruben, Lecanda, Fernando
Publicado 2019

ENPP1 Immunobiology as a Therapeutic Target

por Ruiz-Fernández de Córdoba, Borja, Martínez-Monge, Rafael, Lecanda, Fernando
Publicado 2023

Radiation effects on antitumor immune responses: current perspectives and challenges

por Walle, Thomas, Martinez Monge, Rafael, Cerwenka, Adelheid, Ajona, Daniel, Melero, Ignacio, Lecanda, Fernando
Publicado 2018

CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process

por Habel, Nadia, Stefanovska, Bojana, Carène, Dimitri, Patiño-Garcia, Ana, Lecanda, Fernando, Fromigué, Olivia
Publicado 2019

Connexin43 Deficiency Causes Delayed Ossification, Craniofacial Abnormalities, and Osteoblast Dysfunction

por Lecanda, Fernando, Warlow, Pamela M., Sheikh, Sharmin, Furlan, Federico, Steinberg, Thomas H., Civitelli, Roberto
Publicado 2000

Cpt1c Downregulation Causes Plasma Membrane Remodelling and Anthracycline Resistance in Breast Cancer

por Muley, Helena, Valencia, Karmele, Casas, Josefina, Moreno, Bea, Botella, Luis, Lecanda, Fernando, Fadó, Rut, Casals, Núria
Publicado 2023

Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma

por Rodríguez-Nogales, Carlos, Moreno, Haritz, Zandueta, Carolina, Desmaële, Didier, Lecanda, Fernando, Couvreur, Patrick, Blanco-Prieto, María J.
Publicado 2020

The Usefulness of Bone Biomarkers for Monitoring Treatment Disease: A Comparative Study in Osteolytic and Osteosclerotic Bone Metastasis Models

por Martín-Fernández, Marta, Valencia, Karmele, Zandueta, Carolina, Ormazábal, Cristina, Martínez-Canarias, Susana, Lecanda, Fernando, de la Piedra, Concepción
Publicado 2017

Sphere-derived tumor cells exhibit impaired metastasis by a host-mediated quiescent phenotype

por Bleau, Anne-Marie, Zandueta, Carolina, Redrado, Miriam, Martínez-Canarias, Susana, Larzábal, Leyre, Montuenga, Luis M., Calvo, Alfonso, Lecanda, Fernando
Publicado 2015

FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo

por Brun, Julia, Dieudonné, François-Xavier, Marty, Caroline, Müller, Judith, Schüle, Roland, Patiño-García, Ana, Lecanda, Fernando, Fromigué, Olivia, Marie, Pierre J.
Publicado 2013

Wnt signaling and Loxl2 promote aggressive osteosarcoma

por Matsuoka, Kazuhiko, Bakiri, Latifa, Wolff, Lena I., Linder, Markus, Mikels-Vigdal, Amanda, Patiño-García, Ana, Lecanda, Fernando, Hartmann, Christine, Sibilia, Maria, Wagner, Erwin F.
Publicado 2020

EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth

por Perurena, Naiara, Zandueta, Carolina, Martínez-Canarias, Susana, Moreno, Haritz, Vicent, Silvestre, Almeida, Ana S., Guruceaga, Elisabet, Gomis, Roger R., Santisteban, Marta, Egeblad, Mikala, Hermida, José, Lecanda, Fernando
Publicado 2017

Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcoma

por Georges, Steven, Calleja, Lidia Rodriguez, Jacques, Camille, Lavaud, Melanie, Moukengue, Brice, Lecanda, Fernando, Quillard, Thibaut, Gabriel, Marta Tellez, Cartron, Pierre-François, Baud’huin, Marc, Lamoureux, François, Heymann, Dominique, Ory, Benjamin
Publicado 2018

Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1

por Weekes, Daniel, Kashima, Takeshi G, Zandueta, Carolina, Perurena, Naiara, Thomas, David P, Sunters, Andrew, Vuillier, Céline, Bozec, Aline, El-Emir, Ethaar, Miletich, Isabelle, Patiño-Garcia, Ana, Lecanda, Fernando, Grigoriadis, Agamemnon E
Publicado 2015

Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood

por Rodríguez‐Pena, Alejandro, Armendariz, Estibaliz, Oyarbide, Alvaro, Morales, Xabier, Ortiz‐Espinosa, Sergio, Ruiz‐Fernández de Córdoba, Borja, Cochonneau, Denis, Cornago, Iñaki, Heymann, Dominique, Argemi, Josepmaría, D'Avola, Delia, Sangro, Bruno, Lecanda, Fernando, Pio, Ruben, Cortés‐Domínguez, Iván, Ortiz‐de‐Solórzano, Carlos
Publicado 2022

The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer

por Entrialgo-Cadierno, Rodrigo, Cueto-Ureña, Cristina, Welch, Connor, Feliu, Iker, Macaya, Irati, Vera, Laura, Morales, Xabier, Michelina, Sandra Vietti, Scaparone, Pietro, Lopez, Ines, Darbo, Elodie, Erice, Oihane, Vallejo, Adrian, Moreno, Haritz, Goñi-Salaverri, Ainhoa, Lara-Astiaso, David, Halberg, Nils, Cortes-Dominguez, Ivan, Guruceaga, Elizabeth, Ambrogio, Chiara, Lecanda, Fernando, Vicent, Silve
Publicado 2023

Correction: The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer

por Entrialgo‑Cadierno, Rodrigo, Cueto‑Ureña, Cristina, Welch, Connor, Feliu, Iker, Macaya, Irati, Vera, Laura, Morales, Xabier, Michelina, Sandra Vietti, Scaparone, Pietro, Lopez, Ines, Darbo, Elodie, Erice, Oihane, Vallejo, Adrian, Moreno, Haritz, Goñi‑Salaverri, Ainhoa, Lara‑Astiaso, David, Halberg, Nils, Cortes‑Dominguez, Ivan, Guruceaga, Elizabeth, Ambrogio, Chiara, Lecanda, Fernando, Vicent, Silve
Publicado 2023

An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer

por Vallejo, Adrian, Perurena, Naiara, Guruceaga, Elisabet, Mazur, Pawel K., Martinez-Canarias, Susana, Zandueta, Carolina, Valencia, Karmele, Arricibita, Andrea, Gwinn, Dana, Sayles, Leanne C., Chuang, Chen-Hua, Guembe, Laura, Bailey, Peter, Chang, David K., Biankin, Andrew, Ponz-Sarvise, Mariano, Andersen, Jesper B., Khatri, Purvesh, Bozec, Aline, Sweet-Cordero, E. Alejandro, Sage, Julien, Lecanda, Fernando, Vicent, Silve
Publicado 2017

The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas

por Valencia, Karmele, Erice, Oihane, Kostyrko, Kaja, Hausmann, Simone, Guruceaga, Elizabeth, Tathireddy, Anuradha, Flores, Natasha M., Sayles, Leanne C., Lee, Alex G., Fragoso, Rita, Sun, Tian-Qiang, Vallejo, Adrian, Roman, Marta, Entrialgo-Cadierno, Rodrigo, Migueliz, Itziar, Razquin, Nerea, Fortes, Puri, Lecanda, Fernando, Lu, Jun, Ponz-Sarvise, Mariano, Chen, Chang-Zheng, Mazur, Pawel K., Sweet-Cordero, E. Alejandro, Vicent, Silvestre
Publicado 2020

Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer

por Macaya, Irati, Roman, Marta, Welch, Connor, Entrialgo-Cadierno, Rodrigo, Salmon, Marina, Santos, Alba, Feliu, Iker, Kovalski, Joanna, Lopez, Ines, Rodriguez-Remirez, Maria, Palomino-Echeverria, Sara, Lonfgren, Shane M., Ferrero, Macarena, Calabuig, Silvia, Ludwig, Iziar A., Lara-Astiaso, David, Jantus-Lewintre, Eloisa, Guruceaga, Elizabeth, Narayanan, Shruthi, Ponz-Sarvise, Mariano, Pineda-Lucena, Antonio, Lecanda, Fernando, Ruggero, Davide, Khatri, Purvesh, Santamaria, Enrique, Fernandez-Irigoyen, Joaquin, Ferrer, Irene, Paz-Ares, Luis, Drosten, Matthias, Barbacid, Mariano, Gil-Bazo, Ignacio, Vicent, Silve
Publicado 2023